Why sales volume will fall, page-7

Thanks Lairy..... so justbob turns out to be yet another self-serving 2 faced git.... DYOR for sure.... as for the sales of axiron.... here's my 2 bits worth..... (my own opinion only)- it is a drug that should only be prescribed for a specific medical condition, and reading the FDA report it is clear that any connection to complications in other groups of people (who shouldn't be taking it anyway!) is merely correlational. So middle aged obese men with multiple problems (eg hypertension, type 2 diabetes etc) who turn to testosterone products to... ahem.... boost 'performance'.... are already candidates for cardiovascular issues. ACR is already doing the kinds of studies the FDA report suggests should be done. Once multifactorial analysis is completed of the data set, would be gob smacked if exogenous testosterone turns out to be the most prominent causal factor. The FDA report basically says that anyway, but guess they are covering their butts in litigation happy USA by suggesting further studies.